Cargando…

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

The inaccuracy of the early diagnosis of Parkinson's disease (PD) has been a major incentive for studies aimed at the identification of biomarkers. Brain-derived cerebrospinal fluid (CSF) proteins are potential biomarkers considering the major role that proteins play in PD pathogenesis. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Karin D., Teunissen, Charlotte E., Drukarch, Benjamin, Jimenez, Connie R., Groenewegen, Henk J., Berendse, Henk W., van de Berg, Wilma D.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126274/ https://www.ncbi.nlm.nih.gov/pubmed/20451609 http://dx.doi.org/10.1016/j.nbd.2010.04.020

Ejemplares similares

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
por: Chatterjee, Madhurima, et al.
Publicado: (2020)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations
por: Hepp, Dagmar H., et al.
Publicado: (2017)

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
por: Oosterveld, Linda P., et al.
Publicado: (2019)

Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease
por: Hepp, Dagmar H., et al.
Publicado: (2023)

Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study
por: Verhoeff, Merel Charlotte, et al.
Publicado: (2022)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease
por: Oosterveld, Linda P., et al.
Publicado: (2020)

Anterior insular network disconnection and cognitive impairment in Parkinson’s disease
por: Fathy, Yasmine Y., et al.
Publicado: (2020)

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
por: Del Campo Milan, Marta, et al.
Publicado: (2015)

Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies
por: Heming, Michael, et al.
Publicado: (2019)

Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients
por: Doorn, Karlijn J, et al.
Publicado: (2014)

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review
por: Verhoeff, Merel C., et al.
Publicado: (2022)

Clinicians’ view on the management of oral health in Parkinson’s disease patients: a qualitative study
por: Verhoeff, Merel C., et al.
Publicado: (2023)

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
por: Teunissen, Charlotte E., et al.
Publicado: (2016)

Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis
por: Fathy, Yasmine Y., et al.
Publicado: (2019)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Cognitive Training in Parkinson’s Disease Induces Local, Not Global, Changes in White Matter Microstructure
por: Vriend, Chris, et al.
Publicado: (2021)

Flavor perception and the risk of malnutrition in patients with Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2018)

Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
por: van Deursen, Dagmar N., et al.
Publicado: (2020)

Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence
por: Rutten, Sonja, et al.
Publicado: (2012)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Eight-week multi-domain cognitive training does not impact large-scale resting-state brain networks in Parkinson’s disease
por: van Balkom, Tim D., et al.
Publicado: (2022)

Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder
por: Kamps, Sanne, et al.
Publicado: (2018)

Cerebrospinal fluid collection: An informative animation video for patients and caregivers
por: Babapour Mofrad, R., et al.
Publicado: (2019)

Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease
por: Rimmelzwaan, Lisanne M., et al.
Publicado: (2016)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Volume transmission of beta-endorphin via the cerebrospinal fluid; a review
por: Veening, Jan G, et al.
Publicado: (2012)

Impaired planning in Parkinson's disease is reflected by reduced brain activation and connectivity
por: Trujillo, James P., et al.
Publicado: (2015)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ(1-42), T-tau, and P-tau values
por: Willemse, Eline A.J., et al.
Publicado: (2017)

The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review
por: Veening, Jan G, et al.
Publicado: (2010)

Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery
por: Waury, Katharina, et al.
Publicado: (2023)

Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population
por: Roos, Dareia S., et al.
Publicado: (2022)

Inflammatory cerebrospinal fluid analysis in cats: clinical diagnosis and outcome
por: Singh, M., et al.
Publicado: (2005)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
por: Pijnenburg, Yolande A.L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5i43a4aje8dkur1pa1suj6vqdc